FDA Approves COPD Treatment Bevespi Aerosphere, a Long-acting Dual Bronchodilator
Chronic Bronchitis, COPD, Emphysema, News
The U.S. FDA has approval AstraZeneca’s Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) for long-term maintenance treatment of airflow obstruction in patients suffering from chronic obstructive pulmonary disease (COPD), including emphysema and/or chronic bronchitis. ... Read more